You are here: Home » Current Affairs » Coronavirus » News
Covid-19: Hand sanitiser turns money-spinner, UP earns Rs 100 cr in revenue
India Coronavirus Dispatch: How the country got to a million Covid-19 cases
Business Standard

Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Topics
Bharat Biotech | COVID-19 | Coronavirus Vaccine

Press Trust of India 



Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Haryana Health Minister Vij said

The human trial of Bharat Biotech's anti- vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Fri, July 17 2020. 16:29 IST

RECOMMENDED FOR YOU